Guided Therapeutics Inc (GTHP)

[SolidRockCM]

$GTHP and Shenghuo to work with ~$1.8B company for commercialization of LuViva FORM 8-K June,8 2016

To establish commercialization in China and Ease Asia Shenghuo has established relationships with two Chinese medical device regulatory companies and has developed a strategy for gaining regulatory approval for LuViva in China. This includes the following:

· Investments and technical support from the family behind Xi’an International Medical Investment Co Ltd. Xi’an International Medical Investment Co Ltd is principally engaged in the medical services industry. It has a market cap of approximately ¥ 11.79 B, ~$1.8B. . Xi’an operates its businesses primarily through the investment and management of medical stores, properties and services, including the development of large hospital systems. The Company operates its businesses mainly in Xi'an, Shaanxi province, China.


· A working relationship with one of China’s foremost medical academic institutions, Peking University, as well as its commercial development arm, Founders Group (“FG”). FG has determined that LuViva has potential in the Chinese market and is currently performing due diligence on the LuViva technology and its market potential in Asia. Representatives from Shenghuo have met with FG in Beijing.